Its Stock Has Paid Off Big Time For OPKO Health Inc.

OPKO Health Inc. (NASDAQ: OPK) stock fell -0.41% on Friday to $2.44 against a previous-day closing price of $2.45. With 3.17 million shares changed hands, the volume of the stock remained lighter than its average volume of 4.43 million shares. During the session, the Diagnostics & Research company that operates in wider Healthcare sector, reached to the highest price of $2.5100 whereas the lowest price it dropped to was $2.4300. The 52-week range on OPK shows that it touched its highest point at $5.25 and its lowest point at $2.17 during that stretch. It currently has a 1-year price target of $6.50. Beta for the stock currently stands at 1.80.

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .

Sponsored

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of OPK was down-trending over the past week, with a drop of -1.21%, but this was down by -7.92% over a month. Three-month performance dropped to -15.57% while six-month performance fell -20.26%. The stock lost -32.41% in the past year, while it has lost -49.27% so far this year. A look at the trailing 12-month EPS for OPK yields -0.18 with Next year EPS estimates of -0.10. For the next quarter, that number is 0.01. This implies an EPS growth rate of -197.40% for this year and 95.50% for next year. EPS is expected to grow by 12.00% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 11.90%.

Float and Shares Shorts:

At present, 660.30 million OPK shares are outstanding with a float of 331.23 million shares on hand for trading. On Jul 14, 2022, short shares totaled 48.68 million, which was 7.14% higher than short shares on Jun 14, 2022. In addition to Dr. Phillip Frost Ph.D. as the firm’s Chairman & CEO, Dr. Jane H. Hsiao M.B.A., MBA, Ph.D. serves as its Vice Chairman & Chief Technical Officer.

Institutional Ownership:

Through their ownership of 29.39% of OPK’s outstanding shares, institutional investors have minority control over the company. Other institutions hold 45.30% of OPK, in contrast to 18.97% held by mutual funds. Shares owned by individuals account for 11.12%. As the largest shareholder in OPK with 5.20% of the stake, The Vanguard Group, Inc. holds 35,416,597 shares worth 35,416,597. A second-largest stockholder of OPK, BlackRock Fund Advisors, holds 28,589,296 shares, controlling over 4.20% of the firm’s shares. SSgA Funds Management, Inc. is the third largest shareholder in OPK, holding 27,688,831 shares or 4.06% stake. With a 2.00% stake in OPK, the Vanguard Total Stock Market Index is the largest stakeholder. A total of 13,603,337 shares are owned by the mutual fund manager. The Vanguard Small Cap Index Fund, which owns about 1.71% of OPK stock, is the second-largest Mutual Fund holder. It holds 11,669,096 shares valued at 29.52 million. iShares Russell 2000 ETF holds 1.34% of the stake in OPK, owning 9,146,797 shares worth 23.14 million.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for OPK since 5 analysts follow the stock currently. There are 4 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 1 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With OPK analysts setting a high price target of $8.50 and a low target of $5.00, the average target price over the next 12 months is $6.50. Based on these targets, OPK could surge 248.36% to reach the target high and rise by 104.92% to reach the target low. Reaching the average price target will result in a growth of 166.39% from current levels.

EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. OPK will report FY 2022 earnings on 02/23/2023. Analysts have provided yearly estimates in a range of -$0.09 being high and -$0.34 being low. For OPK, this leads to a yearly average estimate of -$0.24. The earnings surprise of a firm occurs when the actual results change from the consensus earnings estimate. OPKO Health Inc. surprised analysts by -$0.02 when it reported -$0.08 EPS against a consensus estimate of -$0.06. The surprise factor in the prior quarter was -$0.09. Based on analyst estimates, the high estimate for the next quarter is $0.07 and the low estimate is -$0.06. The average estimate for the next quarter is thus $0.01.

Summary of Insider Activity:

Insiders traded OPK stock several times over the past three months with 88 Buys and 0 Sells. In these transactions, 81,460,751 shares were bought while 0 shares were sold. The number of buy transactions has increased to 158 while that of sell transactions has remained unmoved to 0 over the past year. The total number of shares bought during that period was 83,245,761 while 0 shares were sold.

Leave a Comment

Your email address will not be published.

[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]